{
  "main_header": {
    "sid": 396654,
    "name": "Sunil Healthcare",
    "stock_name": "Sunil Healthcare",
    "full_name": "Sunil Healthcare Ltd",
    "name_url": "stocks-analysis/sunil-healthcare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "62.50",
    "chg": 1.5,
    "chgp": "2.46%",
    "dir": 1,
    "prev_price": "61.00",
    "mcapval": "66.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537253,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE671C01016",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "4.12 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sunil-healthcare-396654-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 86,
    "sid": "396654",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sunil-healthcare-396654"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation of Closure of Trading Window for the declaration of audited financial results for the 4th quarter/ financial year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Feb-2026",
      "details": "Newspaper clippings regarding publication of un-audited financial results for 3rd quarter/9 months ended 31st December 2025 (both standalone and consolidated)",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026",
      "datetime": "06-Feb-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are pleased to inform that the Board of Directors of the Company at their Board Meeting held on Friday February 06 2026 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 3rd quarter/ nine months ended December 31 2025 of the FY 2025-26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News